13G Filing: Visium Asset Management Has Nearly Doubled Its Stake in La Jolla Pharmaceutical Co (LJPC)

Page 6 of 12

Page 6 of 12 SEC Filing


CUSIP No. 503459604 Page
6
of 12Pages
Item 1 (a)  Name of Issuer:
 La Jolla Pharmaceutical Company
(b)  Address of Issuers Principal Executive Offices:
 10182 Telesis Court, 6th Floor
 San Diego, CA 92121
Item 2 (a)  (c) This statement is filed on behalf of the following:
(1) Visium Balanced Master Fund, Ltd., a Cayman Islands corporation (VBMF), with its principal business office c/o Visium Asset Management, LP, 888 Seventh Avenue, New York, NY 10019.
(2) Visium Asset Management, LP, a Delaware limited partnership (VAM), with its principal business office c/o Visium Asset Management, LP, 888 Seventh Avenue, New York, NY 10019.
(3) JG Asset, LLC, a Delaware limited liability company (JG Asset), with its principal business office c/o Visium Asset Management, LP, 888 Seventh Avenue, New York, NY 10019. JG Asset is the General Partner of
VAM.
(4) Jacob Gottlieb (Gottlieb), a natural person, with his principal business office c/o Visium Asset Management, LP, 888 Seventh Avenue, New York, NY 10019. Gottlieb is the Managing Member of JG Asset.
(d) Title of Class of Securities:

Common Stock, par value $0.0001 per share

(e) CUSIP Number:

503459604

Page 6 of 12 Pages

Follow La Jolla Pharmaceutical Co (NASDAQ:LJPC)

Page 6 of 12